BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Diagnosis
46 results:

  • 1. liver transplantation for advanced-stage primary hepatic yolk sac tumor: A case report and literature review.
    Liu GH; Qiu MK; Wang Y; Zhang TT; Wang LJ; Guan WB; Ou JM; Chen LT
    Medicine (Baltimore); 2023 Dec; 102(50):e35821. PubMed ID: 38115376
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
    Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
    BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary inflammatory myofibroblastic tumour of the liver: a clinicopathological and genetic study including a subset with ETV6::Ntrk3 fusion.
    Han Q; Zhang Z; He X; Chen M; Pang X; Chen C; Du T; Zhang H
    Histopathology; 2023 May; 82(6):925-936. PubMed ID: 36748182
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The differences in distant metastatic patterns and their corresponding survival between thyroid cancer subtypes.
    Vuong HG; Le MK; Hassell L; Kondo T; Kakudo K
    Head Neck; 2022 Apr; 44(4):926-932. PubMed ID: 35076146
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Breast metastasis from medullary carcinoma of thyroid: A case report with literature view.
    Mukhtar R; Hussain M; Mukhtar MA; Ali SM
    J Pak Med Assoc; 2020 Nov; 70(11):2051-2053. PubMed ID: 33341859
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Antitumor Activity of Larotrectinib in Esophageal Carcinoma with Ntrk Gene Amplification.
    Hempel D; Wieland T; Solfrank B; Grossmann V; Steinhard J; Frick A; Hempel L; Eberl T; Gaumann A
    Oncologist; 2020 Jun; 25(6):e881-e886. PubMed ID: 32323889
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Imaging of medullary thyroid carcinoma].
    Uhrig M; Delorme S
    Radiologe; 2019 Nov; 59(11):992-1001. PubMed ID: 31367891
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A novel combined transoral and transcervical surgical approach for recurrent metastatic medullary thyroid cancer to the parapharyngeal space.
    Lajud SA; Aponte-Ortiz JA; Garraton M; Giraldez L
    J Robot Surg; 2020 Feb; 14(1):233-236. PubMed ID: 30689166
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. DM1 Loaded Ultrasmall Gold Nanoparticles Display Significant Efficacy and Improved Tolerability in Murine Models of Hepatocellular Carcinoma.
    Hale SJM; Perrins RD; Garcı A CE; Pace A; Peral U; Patel KR; Robinson A; Williams P; Ding Y; Saito G; Rodriguez MÁ; Perera I; Barrientos A; Conlon K; Damment S; Porter J; Coulter T
    Bioconjug Chem; 2019 Mar; 30(3):703-713. PubMed ID: 30582799
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Medullary thyroid carcinoma with breast metastasis: Two case reports.
    Meng K; Chen W; Tian W; Sun K; Chen H
    Medicine (Baltimore); 2018 Nov; 97(47):e13193. PubMed ID: 30461619
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Contrast-enhanced ultrasound diagnosis of hepatic metastasis of concurrent medullary-papillary thyroid carcinoma: A case report.
    Zhou J; Luo Y; Ma BY; Ling WW; Zhu XL
    Medicine (Baltimore); 2017 Dec; 96(50):e9065. PubMed ID: 29390301
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A rare case of medullary carcinoma thyroid metastasizing to bilateral breast parenchyma.
    Hassan A; Siddiqui M; Jahangir S
    Nucl Med Rev Cent East Eur; 2016; 19(B):17-19. PubMed ID: 27900756
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical and genetic determinants of ovarian metastases from colorectal cancer.
    Ganesh K; Shah RH; Vakiani E; Nash GM; Skottowe HP; Yaeger R; Cercek A; Lincoln A; Tran C; Segal NH; Reidy DL; Varghese A; Epstein AS; Sonoda Y; Chi D; Guillem J; Temple L; Paty P; Hechtman J; Shia J; Weiser M; Aguilar JG; Kemeny N; Berger MF; Saltz L; Stadler ZK
    Cancer; 2017 Apr; 123(7):1134-1143. PubMed ID: 27875625
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Medullary Thyroid Carcinoma: Imaging.
    Delorme S; Raue F
    Recent Results Cancer Res; 2015; 204():91-116. PubMed ID: 26494385
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Lymph node and distant metastases of thyroid gland cancer. Metastases in the thyroid glands].
    Schmid KW
    Pathologe; 2015 Nov; 36 Suppl 2():171-5. PubMed ID: 26357953
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Case of multiple endocrine neoplasia 2B with probable ectopic adrenocorticotropic hormone-secreting liver metastasis from medullary thyroid carcinoma.
    Kurozumi A; Okada Y; Arao T; Nakamoto Y; Togashi K; Tanaka Y
    J UOEH; 2013 Sep; 35(3):193-9. PubMed ID: 24077587
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Medullary thyroid cancer secreting carbohydrate antigen 19-9 (Ca 19-9): a fatal case report.
    Elisei R; Lorusso L; Romei C; Bottici V; Mazzeo S; Giani C; Fiore E; Torregrossa L; Insilla AC; Basolo F; Guerini A; Menghi A; Poletti A; Cugudda L; Vitti P
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3550-4. PubMed ID: 23861463
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Metachronous appearance of second malignancies in medullary thyroid carcinoma (mtc) patients: a diagnostic challenge and brief review of the literature.
    Alevizaki M; Kyratzoglou E; Bamias A; Tzanela M; Dimopoulos MA; Saltiki K
    Endocrine; 2013 Dec; 44(3):610-5. PubMed ID: 23608930
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
    Gómez-Camarero P; Ortiz-de Tena A; Borrego-Dorado I; Vázquez-Albertino RJ; Navarro-González E; Ruiz-Franco-Baux JV; Cuenca-Cuenca JI
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):261-6. PubMed ID: 23067528
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Metastatic medullary thyroid cancer presenting with elevated levels of CA 19-9 and CA 125.
    Milman S; Whitney KD; Fleischer N
    Thyroid; 2011 Aug; 21(8):913-6. PubMed ID: 21751886
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.